학술논문
Beneficial effect of interferon-β 1b treatment in patients with relapsing–remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy
Document Type
Article
Author
Source
In Journal of Neuroimmunology 2004 148(1):206-211
Subject
Language
ISSN
0165-5728